Utama › Mesotelioma › New York › New York City
Kajian klinikal Mesotelioma di New York City, NY
10 kajian untuk Mesotelioma sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Mengambil pesertaFasa 1
- Columbia University Irving Medical Center, New York
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Mengambil pesertaKajian pemerhatian
- NYU Langone Medical Center, New York
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Mengambil peserta
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Mengambil pesertaFasa 1/2
- New York University Langone Health, New York
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Mengambil pesertaFasa 1
- David H Koch, Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- NYU Langone Medical Center, New York
A Study of Sacituzumab Govitecan in People With Mesothelioma
Mengambil pesertaFasa 2
- Memorial Sloan - Kettering Cancer Center, New York
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Memorial Sloan Kettering Cancer Center, New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Mengambil pesertaFasa 1/2
- Weill Cornell Medicine, Cornell University (site 126), New York
Kajian Mesotelioma di bandar lain
- Houston, TX15 kajian
- Washington, DC9 kajian
- Chicago, IL9 kajian
- Boston, MA8 kajian
- Nashville, TN8 kajian
- Los Angeles, CA6 kajian
- Arlington, VA6 kajian
- Pittsburgh, PA6 kajian
- Philadelphia, PA6 kajian
- Seattle, WA6 kajian
- Edison, NJ5 kajian
- Rochester, MN5 kajian
Kajian lain di New York City
- Kanser Payudara136 kajian
- Kanser Paru-paru Bukan Sel Kecil121 kajian
- Kanser (semua jenis)109 kajian
- Kanser Prostat103 kajian
- Kanser Metastatik93 kajian
- Kanser Kolorektal78 kajian
- Kanser Ovari69 kajian
- Kanser Paru-paru60 kajian
- Mieloma Pelbagai60 kajian
- Kanser Pankreas60 kajian
- Kanser Endometrium52 kajian
- Leukemia Mieloid Akut51 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.